Christopher Patusky Sells 1,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock

United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) Director Christopher Patusky sold 1,000 shares of the business's stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $578.88, for a total transaction of $578,880.00. Following the transaction, the director directly owned 1,490 shares of the company's